Paul M Hwang

9PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMetabolic medicineMicroelectromechanical systems (MEMS)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 03, 2026
The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development.

Erli Wang, Liangzi Cao, Wendong Guo

|Feb 17, 2025
Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Abu Mohammad Syed, Alexander K Karius, Jin Ma

|Aug 14, 2023
WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.

Ping-Yuan Wang, Jin Ma, Young-Chae Kim

|Apr 17, 2023
Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death.

Joshua H Choe, Tatsuya Kawase, An Xu

|Sep 30, 2021
Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.

Masahiro Nishi, Ping-Yuan Wang, Paul M Hwang

|Jul 08, 2021
Mitochondria and oxygen homeostasis.

Mateus P Mori, Rozhin Penjweini, Jay R Knutson

Pageof 2

Frequent Collaborators

1 joint publications

Mehdi Pirooznia

1 joint publications

Sharon A Savage

1 joint publications

Phuong L Mai

1 joint publications

Xiaofang Cheng